Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 69,700 | 305,100 | 119,700 | 80,200 | -12,500 |
| Depreciation Amortization | 29,700 | 118,000 | 88,000 | 58,300 | 28,900 |
| Income taxes - deferred | -1,700 | -2,400 | -4,400 | -3,700 | -4,200 |
| Accounts receivable | 42,100 | 49,000 | 74,600 | 12,100 | 108,200 |
| Accounts payable and accrued liabilities | 20,100 | 18,700 | 10,600 | -14,500 | -15,600 |
| Other Working Capital | -107,700 | 8,800 | -14,300 | -11,400 | 38,400 |
| Other Operating Activity | -47,100 | 38,800 | 16,700 | 64,700 | -85,400 |
| Operating Cash Flow | $5,100 | $536,000 | $290,900 | $185,700 | $57,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -56,100 | -141,000 | -105,000 | -59,300 | -24,200 |
| Other Investing Activity | 0 | -10,000 | -10,000 | -10,000 | 0 |
| Investing Cash Flow | $-56,100 | $-151,000 | $-115,000 | $-69,300 | $-24,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -16,200 | 435,900 | 441,600 | N/A | N/A |
| Debt Repayment | N/A | -373,000 | -373,000 | -25,600 | -22,800 |
| Common Stock Issued | 6,900 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -12,900 | 6,600 | 3,200 | 10,300 | 2,800 |
| Financing Cash Flow | $-22,200 | $69,500 | $71,800 | $-15,300 | $-20,000 |
| Exchange Rate Effect | -300 | -1,000 | -500 | -100 | 100 |
| Beginning Cash Position | 621,500 | 168,000 | 168,000 | 168,000 | 168,000 |
| End Cash Position | 548,000 | 621,500 | 415,200 | 269,000 | 181,700 |
| Net Cash Flow | $-73,500 | $453,500 | $247,200 | $101,000 | $13,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,100 | 536,000 | 290,900 | 185,700 | 57,800 |
| Capital Expenditure | -56,100 | -141,000 | -105,000 | -59,300 | -24,200 |
| Free Cash Flow | -51,000 | 395,000 | 185,900 | 126,400 | 33,600 |